Potential adverse effects of ciprofloxacin and tetracycline on ARPE-19 cell lines. Issue 1 (21st July 2020)
- Record Type:
- Journal Article
- Title:
- Potential adverse effects of ciprofloxacin and tetracycline on ARPE-19 cell lines. Issue 1 (21st July 2020)
- Main Title:
- Potential adverse effects of ciprofloxacin and tetracycline on ARPE-19 cell lines
- Authors:
- Salimiaghdam, Nasim
Singh, Lata
Schneider, Kevin
Nalbandian, Angele
Chwa, Marilyn
Atilano, Shari R
Bao, Andrea
Kenney, M Cristina - Abstract:
- Abstract : Background: We aim to determine the possible adverse effects of ciprofloxacin (CPFX) and tetracycline (TETRA), as examples of bactericidal and bacteriostatic agents, respectively, on cultured human retinal pigment epithelial cells (ARPE-19). Methods: Cells were treated with 30, 60 and 120 µg/mL of CPFX and TETRA. Cell metabolism was measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. JC-1 dye (5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazolylcarbocyanine iodide) assay was conducted to measure the mitochondrial membrane potential (MMP). The level of reactive oxygen species (ROS) was measured using the -2', 7'-dichlorodihydrofluorescein diacetate assay (H2DCFDA). Quantitative real-time PCR was performed to analyse the gene expression levels associated with apoptosis ( BAX, BCL2-L13, BCL2, Caspase 3, Caspase 7 and Caspase 9 ), inflammatory (interleukin-1 β ( IL-1β), IL-6, IL-33, transforming growth factor- α (TGF-α), TGF-β1 and TGF-β2 ) and antioxidant pathways ( SOD2, SOD3, GPX3 and NOX4 ), along with the mitochondrial DNA (mtDNA) copy numbers. Results: Results illustrated that while all three concentrations of CPFX decreased cellular viability of ARPE-19 during all incubation periods, the 120 µg/mL TETRA resulted in increased cellular viability. At 48 and 72 hours, levels of MMP and ROS decreased significantly with each antibiotic. BAX, BCL2-L13, CASP-7, CASP-9, SOD2 and GPX3 genes overexpressed by either antibiotics.Abstract : Background: We aim to determine the possible adverse effects of ciprofloxacin (CPFX) and tetracycline (TETRA), as examples of bactericidal and bacteriostatic agents, respectively, on cultured human retinal pigment epithelial cells (ARPE-19). Methods: Cells were treated with 30, 60 and 120 µg/mL of CPFX and TETRA. Cell metabolism was measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. JC-1 dye (5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazolylcarbocyanine iodide) assay was conducted to measure the mitochondrial membrane potential (MMP). The level of reactive oxygen species (ROS) was measured using the -2', 7'-dichlorodihydrofluorescein diacetate assay (H2DCFDA). Quantitative real-time PCR was performed to analyse the gene expression levels associated with apoptosis ( BAX, BCL2-L13, BCL2, Caspase 3, Caspase 7 and Caspase 9 ), inflammatory (interleukin-1 β ( IL-1β), IL-6, IL-33, transforming growth factor- α (TGF-α), TGF-β1 and TGF-β2 ) and antioxidant pathways ( SOD2, SOD3, GPX3 and NOX4 ), along with the mitochondrial DNA (mtDNA) copy numbers. Results: Results illustrated that while all three concentrations of CPFX decreased cellular viability of ARPE-19 during all incubation periods, the 120 µg/mL TETRA resulted in increased cellular viability. At 48 and 72 hours, levels of MMP and ROS decreased significantly with each antibiotic. BAX, BCL2-L13, CASP-7, CASP-9, SOD2 and GPX3 genes overexpressed by either antibiotics. There was higher expression of IL-6 and IL-1B with TETRA treatment. The level of mtDNA decreased using both treatments. Conclusions: Clinically relevant concentrations of CPFX and TETRA have detrimental impacts on ARPE-19 cell lines in vitro, including upregulation of genes related to apoptosis, inflammation and antioxidant pathways. Additional studies are warranted to investigate if these harmful effects might be seen in retinal degeneration models in vivo. … (more)
- Is Part Of:
- BMJ open ophthalmology. Volume 5:Issue 1(2020)
- Journal:
- BMJ open ophthalmology
- Issue:
- Volume 5:Issue 1(2020)
- Issue Display:
- Volume 5, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 5
- Issue:
- 1
- Issue Sort Value:
- 2020-0005-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-07-21
- Subjects:
- retina -- apotosis -- drugs
Ophthalmology -- Periodicals
617.7005 - Journal URLs:
- http://www.bmj.com/archive ↗
http://bmjophth.bmj.com/ ↗ - DOI:
- 10.1136/bmjophth-2020-000458 ↗
- Languages:
- English
- ISSNs:
- 2397-3269
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17126.xml